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第二項  目的 
NMR メタボローム研究に必要な定量的 NMR 測定の条件を調べ、多数試料を連続自
動測定することができるパルスシークエンスプログラムを作成する。 
 






























第四項  結果 
上記最適パラメーターを採用し、血漿用、尿・廃液用の自動測定パルスをそれぞれ

































第三項  目的 
定量分析に必要な内部標準物質とその最適使用条件を探索する。 
 



















































































































































































ザーを血液が通過する時間は約 30 秒と計算された。分子量 100～300 の分子の水中拡

































































図 3-5 にエネルギー代謝異常を報告されていない CGN 患者群（８名）、DN 患者群








































前項までに報告した DN 群は透析歴 4 年以上の患者である。透析歴 1 年未満の糖尿














た 49,50。乳酸/ピルビン酸比（L/P 比）がその指標として用いられ基準値は 10 とされて
いる 57。通常は L/P比を用いるが、ピルビン酸値は大変小さく誤差が大きいので、これ
を分母として比を計算すると扱いづらいので、本報告では逆数の P/L比で議論する。 
図 3-9 に CGN、DN および DN-new の３群について平均値を比較して示した。
DN-new群は P/L比が 0.9程度であり健常値に近い値であったが、DN群は 0.6程度と
大きく低下している。CGN 群はその中間の値をとるが、透析中に値が改善されて行く










































































CGN および DN 患者の NMR スペクトルの主成分分析から計算された PC1 および






































































































血中ビオチン濃度測定対象者は健常者 11 名、痙攣発作を訴える患者 14 名に加えア































































健常者 11名、透析透析患者 27名（痙攣発作のある透析患者 14名および痙攣発作を



















































告がある 53。ELISA 法は 5 員環骨格を認識して検出するので、ビオチンのみでなく、
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標準物質        
DSS(TSP) 
 Yellow：シングルパルス 









METHOD temp_set IS ADVANCED 
  
    GROUP Full_Auto IS 
  
        EXPERIMENT Temp_set IS 
            EXTENSION   "_dummy" 
            SAMPLE_ID   "" runtime 
            COMMENT     "" runtime 
            SLOT        0 runtime 
            SOLVENT     "" runtime 
            TEMPERATURE 25[dC] runtime OFF runtime 
            EXP_FILE    "~GLOBAL_EXPERIMENT/single_pulse.ex2" DO 
                spin_state := "SPIN OFF"; 
                auto_gain := FALSE; 
                recvr_gain := 0; 
                scans := 1; 
                x_prescans := 0; 
                x_angle := 10[deg]; 
                relaxation_delay := 420[s]; 
                process := ""; 
        END EXPERIMENT; 
  




METHOD Presat_only IS ADVANCED 
  
    GROUP Full_Auto IS 
  
        EXPERIMENT SCOUT IS 
            EXTENSION   "_SCOUT" 
            SAMPLE_ID   "" runtime 
            COMMENT     "" runtime 
            SLOT        0 runtime 
      SOLVENT     "" runtime 
      TEMPERATURE 25[dC] runtime OFF runtime 
             EXP_FILE    "~GLOBAL_EXPERIMENT/single_pulse.ex2" DO 
spin_state := "SPIN OFF"; 
                lock_state := "AUTOLOCK"; 
                autoshim_mode := "Z1 Z2"; 
                auto_gain := TRUE; 
                scans := 1; 
                process := ""; 
        END EXPERIMENT; 
  
        EXPERIMENT AutoGain_SGL IS 
            EXTENSION   "_autogain" 
            SAMPLE_ID   "" runtime 
            COMMENT     "" runtime 
            SLOT        0 runtime 
            SOLVENT     "D2O" runtime 
            TEMPERATURE 25[dC] runtime ON runtime 
            EXP_FILE    "~GLOBAL_EXPERIMENT/single_pulse.ex2" DO 
                filter_limit := 128; 
                auto_gain := TRUE; 
                x_points := 65536; 
                scans := 1; 
                x_prescans := 0; 
                relaxation_delay := 4[s]; 
                dante_presat := TRUE; 
                dante_pulse := 4[us]; 
                dante_attenuator := 24[dB]; 
                process := ""; 
                TAKE highest_peak ASSIGN_TO x_offset FROM SCOUT; 
        END EXPERIMENT; 
  
        EXPERIMENT Single_Pulse IS 
            EXTENSION   "_sgl" 
            SAMPLE_ID   "" runtime 
図2-4  臨床応用NMR用連続自働測定プログラム 
（1/10） （2/10） 
COMMENT     "" runtime 
            SLOT        0 runtime 
            SOLVENT     "D2O" runtime 
            TEMPERATURE 25[dC] runtime ON runtime 
            EXP_FILE    "~GLOBAL_EXPERIMENT/single_pulse.ex2" DO 
                filter_limit := 8; 
                auto_gain := FALSE; 
                x_points := 65536; 
                scans := 96; 
                x_prescans := 1; 
 relaxation_delay := 15[s]; 
                dante_presat := TRUE; 
                dante_pulse := 4[us]; 
                dante_attenuator := 20[dB]; 
                process := ""; 
                TAKE highest_peak ASSIGN_TO x_offset FROM SCOUT; 
                TAKE "recvr_gain -3" ASSIGN_TO recvr_gain FROM AutoGain_SGL; 
        END EXPERIMENT; 
  




METHOD Presat_and_T2_filter IS ADVANCED 
  
    GROUP Full_Auto IS 
  
        EXPERIMENT SCOUT IS 
            EXTENSION   "_SCOUT" 
            SAMPLE_ID   "" runtime 
            COMMENT     "" runtime 
            SLOT        0 runtime 
            SOLVENT     "" runtime 
            TEMPERATURE 25[dC] runtime OFF runtime 
            EXP_FILE    "~GLOBAL_EXPERIMENT/single_pulse.ex2" DO 
                spin_state := "SPIN OFF"; 
                lock_state := "AUTOLOCK"; 
 auto_gain := TRUE; 
                scans := 1; 
                process := ""; 
        END EXPERIMENT; 
  
        EXPERIMENT AutoGain_SGL IS 
            EXTENSION   "_autogain" 
            SAMPLE_ID   "" runtime 
            COMMENT     "" runtime 
            SLOT        0 runtime 
            SOLVENT     "D2O" runtime 
            TEMPERATURE 25[dC] runtime ON runtime 
            EXP_FILE    "~GLOBAL_EXPERIMENT/single_pulse.ex2" DO 
                filter_limit := 128; 
 auto_gain := TRUE; 
                x_points := 65536; 
                scans := 1; 
                x_prescans := 0; 
                relaxation_delay := 4[s]; 
                dante_presat := TRUE; 
                dante_pulse := 4[us]; 
                dante_attenuator := 20[dB]; 
                process := ""; 
                TAKE highest_peak ASSIGN_TO x_offset FROM SCOUT; 
        END EXPERIMENT; 
 
  EXPERIMENT Single_Pulse IS 
            EXTENSION   "_sgl" 
            SAMPLE_ID   "" runtime 
            COMMENT     "" runtime 
            SLOT        0 runtime 
            SOLVENT     "D2O" runtime 
            TEMPERATURE 25[dC] runtime ON runtime 
            EXP_FILE    "~GLOBAL_EXPERIMENT/single_pulse.ex2" DO 
 filter_limit := 128; 
                auto_gain := FALSE; 
                x_points := 65536; 
（3/10） （4/10） 
 scans := 256; 
                x_prescans := 1; 
                relaxation_delay := 20[s]; 
                dante_presat := TRUE; 
                dante_pulse := 4[us]; 
                dante_attenuator := 20[dB]; 
                process := ""; 
                TAKE highest_peak ASSIGN_TO x_offset FROM SCOUT; 
                TAKE "recvr_gain -3" ASSIGN_TO recvr_gain FROM AutoGain_SGL; 
        END EXPERIMENT; 
  
        EXPERIMENT AutoGain_T2 IS 
            EXTENSION   "_autogain" 
            SAMPLE_ID   "" runtime 
            COMMENT     "" runtime 
            SLOT        0 runtime 
            SOLVENT     "" runtime 
            TEMPERATURE 25[dC] runtime OFF runtime 
            EXP_FILE    "~GLOBAL_EXPERIMENT/relaxation/cpmg.ex2" DO 
 filter_limit := 16; 
                auto_gain := TRUE; 
                x_points := 65536; 
                scans := 4; 
                x_prescans := 0; 
                relaxation_delay := 2[s]; 
                delay_list := 300[ms]; 
                tau_step := 800[us]; 
                dante_presat := TRUE; 
                dante_pulse := 5[us]; 
                dante_attenuator := 20[dB]; 
                process := ""; 
                TAKE x_sweep, 
                     x_offset FROM Single_Pulse; 
        END EXPERIMENT; 
  
 EXPERIMENT T2_filter IS 
            EXTENSION   "_T2_FILTER" 
 SAMPLE_ID   "" runtime 
            COMMENT     "" runtime 
            SLOT        0 runtime 
            SOLVENT     "" runtime 
            TEMPERATURE 25[dC] runtime OFF runtime 
            EXP_FILE    "~GLOBAL_EXPERIMENT/relaxation/cpmg.ex2" DO 
                filter_limit := 16; 
                auto_gain := FALSE; 
                x_points := 65536; 
                scans := 256; 
                x_prescans := 4; 
                relaxation_delay := 20[s]; 
                delay_list := 300[ms]; 
                tau_step := 800[us]; 
                dante_presat := TRUE; 
                dante_pulse := 5[us]; 
                dante_attenuator := 20[dB]; 
                process := ""; 
                TAKE x_sweep, 
                     x_offset FROM Single_Pulse; 
                TAKE "recvr_gain -12" ASSIGN_TO recvr_gain FROM AutoGain_T2; 
        END EXPERIMENT; 
  




METHOD Jresolv_and_diff IS ADVANCED 
  
    GROUP Full_Auto IS 
  
        EXPERIMENT SCOUT IS 
            EXTENSION   "_SCOUT" 
            SAMPLE_ID   "" runtime 
            COMMENT     "" runtime 
            SLOT        0 runtime 
            SOLVENT     "" runtime 
 
（5/10） （6/10） 
  TEMPERATURE 25[dC] runtime OFF runtime 
            EXP_FILE    "~GLOBAL_EXPERIMENT/single_pulse.ex2" DO 
                spin_state := "SPIN OFF"; 
                lock_state := "AUTOLOCK"; 
                autoshim_mode := "Z1 Z2"; 
                auto_gain := TRUE; 
                scans := 1; 
                process := ""; 
        END EXPERIMENT; 
  
        EXPERIMENT AutoGain_Jreso IS 
            EXTENSION   "_autogain" 
            SAMPLE_ID   "" runtime 
            COMMENT     "" runtime 
            SLOT        0 runtime 
            SOLVENT     "" runtime 
            TEMPERATURE 25[dC] runtime OFF runtime 
            EXP_FILE    
"~GLOBAL_EXPERIMENT/j_resolved/homo_j_resolved.ex2" DO 
                filter_limit := 16; 
                auto_gain := TRUE; 
                round_points := FALSE; 
                x_points := 2048; 
                scans := 1; 
                x_prescans := 0; 
                y_points := 1; 
                relaxation_delay := 2[s]; 
                dante_presat := TRUE; 
                dante_pulse := 5[us]; 
                dante_attenuator := 24[dB]; 
 process := ""; 
                TAKE highest_peak ASSIGN_TO x_offset FROM SCOUT; 
        END EXPERIMENT; 
  EXPERIMENT J-resolve IS 
            EXTENSION   "_J-RESOLVE" 
            SAMPLE_ID   "" runtime 
 COMMENT     "" runtime 
 SLOT        0 runtime 
            SOLVENT     "" runtime 
            TEMPERATURE 25[dC] runtime OFF runtime 
            PROCESSING  "~GLOBAL_PROCESS_LIST/automation/j-
resolved_summation.list" 
            EXP_FILE    
"~GLOBAL_EXPERIMENT/j_resolved/homo_j_resolved.ex2" DO 
                filter_limit := 16; 
                auto_gain := FALSE; 
                round_points := FALSE; 
                x_points := 2048; 
                scans := 4; 
                x_prescans := 4; 
                y_points := 24; 
                relaxation_delay := 2[s]; 
                dante_presat := TRUE; 
                dante_pulse := 5[us]; 
                dante_attenuator := 24[dB]; 
                process := ""; 
                TAKE highest_peak ASSIGN_TO x_offset FROM SCOUT; 
                TAKE recvr_gain ASSIGN_TO recvr_gain-6[dB] FROM 
AutoGain_Jreso; 
        END EXPERIMENT; 
  
        EXPERIMENT AutoGain_diff IS 
            EXTENSION   "_autogain" 
            SAMPLE_ID   "" runtime 
            COMMENT     "" runtime 
            SLOT        0 runtime 
            SOLVENT     "" runtime 
            TEMPERATURE 25[dC] runtime OFF runtime 
            EXP_FILE    "~GLOBAL_EXPERIMENT/diffusion/bpp_led_dosy_pfg.ex2" 
DO 
                filter_limit := 16; 
                auto_gain := TRUE; 
                x_points := 16384; 
                scans := 1; 
（7/10） （8/10） 
 x_prescans := 0; 
                relaxation_delay := 2[s]; 
                diffusion_time := 200[ms]; 
                grad_1 := 2[ms]; 
                grad_1_amp := 100[%]; 
                t_e := 5[ms]; 
                dante_presat := TRUE; 
                dante_pulse := 5[us]; 
                dante_attenuator := 24[dB]; 
                process := ""; 
                TAKE highest_peak ASSIGN_TO x_offset FROM SCOUT; 
        END EXPERIMENT; 
  
        EXPERIMENT diffusion_filter IS 
            EXTENSION   "_DIFFUSION_FILTER" 
            SAMPLE_ID   "" runtime 
            COMMENT     "" runtime 
            SLOT        0 runtime 
            SOLVENT     "" runtime 
            TEMPERATURE 25[dC] runtime OFF runtime 
            PROCESSING  "~GLOBAL_PROCESS_LIST/std_proton.list" 
            EXP_FILE    "~GLOBAL_EXPERIMENT/diffusion/bpp_led_dosy_pfg.ex2" 
DO 
                filter_limit := 16; 
                auto_gain := FALSE; 
                x_points := 16384; 
                scans := 16; 
                x_prescans := 4; 
                relaxation_delay := 2[s]; 
                diffusion_time := 200[ms]; 
                grad_1 := 2[ms]; 
                grad_1_amp := 100[%]; 
                t_e := 5[ms]; 
                dante_presat := TRUE; 
                dante_pulse := 5[us]; 
                dante_attenuator := 24[dB]; 
                process := ""; 
 TAKE highest_peak ASSIGN_TO x_offset FROM SCOUT; 
                TAKE recvr_gain ASSIGN_TO recvr_gain-6[dB] FROM AutoGain_diff; 
        END EXPERIMENT; 
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図2-6a. 蟻酸ピーク 図2-6 b. TSPピーク 
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  Characteristics                Mean ± SD 
   -----------------------------------------------------------  
  Weight (Kg)                        54.7± 8.5  
  SBP (mmHg)                    136.7 ± 9.9  
  DBP (mmHg)                      74.7 ± 17.0 
  UFR (liters/4h)                     2.9 ± 0.5 
  Albumin (g/dl)                     3.8 ± 0.3  
  Haemoglobin (g/dl)          11.3 ± 0.7 
  Haematocrit (%)                33.2 ± 2.0 
  Sodium (mEq/l)               140.1 ± 2.2 
  Phosphorous (mg/dl)          5.8 ± 1.0 
  BUN (mg/dl)                       68.5 ± 13.5 
  Creatinine (mg/dl)             10.1 ± 1.3 
  CPK (IU/l)                          136.4 ± 79.5 
  Glucose (mg/dl)                 95.1 ± 21.7 
  HDL-C (mg/dl)                    48.7 ±12.5 
  LDL-C (mg/dl)                     73.5 ± 30.1  
  Triglyceride (mg/dl)         100.5 ± 59.0 
  Kt/V                                      1.67 ± 0.29 
----------------------------------------------------------- 
 
SBP, systolic blood pressures; DBP, 
diastolic blood pressures; UFR, 
ultrafiltration rate; BUN, blood urea 
nitrogen; CPK, creatine 
phosphokinase; HDL-C, high density 
lipoprotein cholesterol; LDL-C, low 
density lipoprotein cholesterol 
表4-1  Baseline characteristics 
of study patients (n = 14) 
